Local hyperthermia and radiation therapy in the treatment of superficially located lymphomas and recurrent Hodgkin's disease

Author(s):  
V Donato ◽  
A Zurlo ◽  
E Banelli ◽  
M Santarelli ◽  
P Anselmo ◽  
...  
2019 ◽  
Vol 57 ◽  
pp. 100-106 ◽  
Author(s):  
Kalliopi M. Kourinou ◽  
Michalis Mazonakis ◽  
Efrosini Lyraraki ◽  
Helen Α. Papadaki ◽  
John Damilakis

1995 ◽  
Vol 31 (2) ◽  
pp. 227-236 ◽  
Author(s):  
Michael Barton ◽  
John Boyages ◽  
Elizabeth Crennan ◽  
Sidney Davis ◽  
Richard J. Fisher ◽  
...  

Cancer ◽  
1976 ◽  
Vol 37 (4) ◽  
pp. 1625-1632 ◽  
Author(s):  
William C. Cham ◽  
Charlotte T. C. Tan ◽  
Alvaro Martinez ◽  
Philip R. Exelby ◽  
Melvin Tefft ◽  
...  

1985 ◽  
Vol 3 (4) ◽  
pp. 501-505 ◽  
Author(s):  
P M Mauch ◽  
G P Canellos ◽  
D S Rosenthal ◽  
S Hellman

A total of 464 pathologically staged IA through IIIB Hodgkin's disease patients were evaluated for the risk of developing acute nonlymphocytic leukemia, non-Hodgkin's lymphoma, or a fatal infection after treatment with radiation therapy (RT) alone, initial combined radiation therapy and chemotherapy (CMT), or RT with MOPP administered at relapse. Patients received a standard six cycles of MOPP, and additional maintenance chemotherapy was not administered. Patients receiving total nodal irradiation (TNI) and MOPP chemotherapy have an 11.9% actuarial risk of developing a fatal complication at ten years, as compared to a 0.8% risk for lesser field irradiation and MOPP (P = .005). The risk with RT alone is 0.6%. Patients 40 years of age or older have a greater risk for complications. These data report a low risk for fatal complication with CMT when less than TNI is administered and when maintenance chemotherapy is not used.


Cancer ◽  
1991 ◽  
Vol 68 (9) ◽  
pp. 1869-1873 ◽  
Author(s):  
A. L. Zietman ◽  
R. M. Linggood ◽  
A. R. Brookes ◽  
K. Convery ◽  
A. Piro

Sign in / Sign up

Export Citation Format

Share Document